Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemia-Reference-Cited by-同舟云学术

Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemia

Published:2017-11-08 Issue:1 Volume:81 Page:217-222
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Emadi Ashkan^ORCID,Law Jennie Y.,Strovel Erin T.,Lapidus Rena G.,Jeng Linda J. B.,Lee Myounghee,Blitzer Miriam G.,Carter-Cooper Brandon A.,Sewell Danielle,Van Der Merwe Isabella,Philip Sunita,Imran Mohammad,Yu Stephen L.,Li Hongxia,Amrein Philip C.,Duong Vu H.,Sausville Edward A.,Baer Maria R.,Fathi Amir T.,Singh Zeba,Bentzen Søren M.

Funder

Jazz Pharmaceuticals

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-017-3459-6/fulltext.html

Reference18 articles.

1. Buchner T, Schlenk RF, Schaich M, Dohner K, Krahl R, Krauter J, Heil G, Krug U, Sauerland MC, Heinecke A, Spath D, Kramer M, Scholl S, Berdel WE, Hiddemann W, Hoelzer D, Hehlmann R, Hasford J, Hoffmann VS, Dohner H, Ehninger G, Ganser A, Niederwieser DW, Pfirrmann M (2012) Acute myeloid leukemia (AML): different treatment strategies versus a common standard arm—combined prospective analysis by the German AML intergroup. J Clin Oncol 30(29):3604–3610. doi: 10.1200/JCO.2012.42.2907

2. Estey E, Levine RL, Lowenberg B (2015) Current challenges in clinical development of “targeted therapies”: the case of acute myeloid leukemia. Blood 125(16):2461–2466. doi: 10.1182/blood-2015-01-561373

3. Willems L, Jacque N, Jacquel A, Neveux N, Maciel TT, Lambert M, Schmitt A, Poulain L, Green AS, Uzunov M, Kosmider O, Radford-Weiss I, Moura IC, Auberger P, Ifrah N, Bardet V, Chapuis N, Lacombe C, Mayeux P, Tamburini J, Bouscary D (2013) Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia. Blood 122(20):3521–3532. doi: 10.1182/blood-2013-03-493163